Coronavirus Antigen Detection Test System.
Main Filters
Coronavirus Antigen Detection Test System.
| ADVIN BIOTECH, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| ABCass(1)-CAN-AO | 0 | - | ||
| ABCass(2)-CAN-AO | 0 | - | ||
| ABCass(5)-CAN-AO | 0 | - | ||
| Beijing Hotgen Biotech Co., Ltd. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 10T/kit | 0 | - | ||
| 1T/kit | 0 | - | ||
| 20T/kit | 0 | - | ||
| 2T/Kit | 0 | - | ||
| 40T/kit | 0 | - | ||
| 5T/kit | 0 | - | ||
| Core Technology Co.,Ltd. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| BP291-1 | 0 | - | ||
| BP291-5 | 0 | - | ||
| CORETESTS, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| CO291-10 | 0 | - | ||
| CO291-10 | 0 | - | ||
| CO291-2 | 0 | - | ||
| CO291-5 | 0 | - | ||
| CO291-8 | 0 | - | ||
| Genbody Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| COVAG025-NU | 0 | - | ||
| COVAG025-NU-1 | 0 | - | ||
| COVAG025-U | 0 | - | ||
| COVAGHT2-U-01 | 0 | - | ||
| COVAGHT2-U-02 | 0 | - | ||
| COVAGHT2-U-05 | 0 | - | ||
| COVAGHT2-U-25 | 0 | - | ||
| IHEALTH LAB INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| ICO-3000 | 0 | - | ||
| ICO-3000 | 0 | - | ||
| ICO-3000 | 0 | - | ||
| INBIOS INTERNATIONAL, INC | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| CAGS-2 | 0 | - | ||
| COVAG-RC | 0 | - | ||
| LUMIQUICK DIAGNOSTICS, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 1N40C5-1-US-BS | 0 | - | ||
| MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| MDSC01 | 0 | - | ||
| MDSC02 | 0 | - | ||
| MGPF25 | 0 | - | ||
| MPF25 | 0 | - | ||
| ORTHO-CLINICAL DIAGNOSTICS, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 6199943 | 0 | - | ||
| 6199944 | 0 | - | ||
| 6199949 | 0 | - | ||
| 6199950 | 0 | - | ||
| PRINCETON BIOMEDITECH CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| BSP-511-25 | 0 | - | ||
| QUIDEL CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 20398 | 0 | - | ||
| 20399 | 0 | - | ||
| 20402 | 0 | - | ||
| Xiamen Boson Biotech Co., Ltd. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 1N40C5-1-US | 0 | - | ||
| 1N40C5-10-US | 0 | - | ||
| 1N40C5-2-US | 0 | - | ||
| 1N40C5-2-US | 0 | - | ||
| 1N40C5-20-US | 0 | - | ||
| 1N40C5-4-US | 0 | - | ||
| 1N40C5-40-US | 0 | - | ||
| 1N40C5-5-US | 0 | - | ||
| 1N40C5-8-US | 0 | - | ||
131 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
VITROS
ORTHO-CLINICAL DIAGNOSTICS, INC.
VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Calibrator
0
-
VITROS
ORTHO-CLINICAL DIAGNOSTICS, INC.
VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reagent Pack
0
-
VITROS
ORTHO-CLINICAL DIAGNOSTICS, INC.
VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Extraction Buffer
0
-
VITROS
ORTHO-CLINICAL DIAGNOSTICS, INC.
VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Controls
0
-
Status™ COVID-19/Flu
PRINCETON BIOMEDITECH CORPORATION
Status™ COVID-19/Flu A&B Antigen test kit, 25 tests
0
-
Gazelle PathoCatch
MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED
COVID-19 Antigen Fluorescence Immunoassay Kit
0
-
PathoCatch
MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED
COVID-19 Antigen Fluorescence Immunoassay Kit
0
-
GenBody COVID-19 Ag
Genbody Inc.
Qualitative detection of nucleocapsid protein antigen from SARSCoV-2 anterior nasal (AN) swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six days of symptom onset. For use under an emergency use authorization (EUA) only.
0
-
GenBody COVID-19 Ag Home Test
Genbody Inc.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. For use under an emergency use authorization (EUA) only.
0
-
GenBody COVID-19 Ag Home Test
Genbody Inc.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. For use under an emergency use authorization (EUA) only.
0
-
GenBody COVID-19 Ag Home Test
Genbody Inc.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. For use under an emergency use authorization (EUA) only.
0
-
GenBody COVID-19 Ag
Genbody Inc.
Qualitative detection of nucleocapsid protein antigen from SARSCoV-2 anterior nasal (AN) swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six days of symptom onset. For use under an emergency use authorization (EUA) only.
0
-
GenBody COVID-19 Ag
Genbody Inc.
Qualitative detection of nucleocapsid protein antigen from SARSCoV-2 in direct nasopharyngeal swab (NP) specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six days of symptom onset. Emergency use of this test is limited to authorized laboratories.
0
-
GenBody COVID-19 Ag Home Test
Genbody Inc.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. For use under an emergency use authorization (EUA) only.
0
-
Hotgen™ COVID-19 Antigen Home Test
Beijing Hotgen Biotech Co., Ltd.
Hotgen™ COVID-19 Antigen Home Test (Model: 40T/kit)
0
-
Hotgen™ COVID-19 Antigen Home Test
Beijing Hotgen Biotech Co., Ltd.
Hotgen™ COVID-19 Antigen Home Test (Model: 20T/kit)
0
-
Hotgen™ COVID-19 Antigen Home Test
Beijing Hotgen Biotech Co., Ltd.
Hotgen™ COVID-19 Antigen Home Test (Model: 10T/kit)
0
-
Hotgen™ COVID-19 Antigen Home Test
Beijing Hotgen Biotech Co., Ltd.
Hotgen™ COVID-19 Antigen Home Test (Model: 5T/kit)
0
-
Hotgen™ COVID-19 Antigen Home Test
Beijing Hotgen Biotech Co., Ltd.
Hotgen™ COVID-19 Antigen Home Test (Model: 1T/kit)
0
-
Hotgen™ COVID-19 Antigen Home Test
Beijing Hotgen Biotech Co., Ltd.
Hotgen™ COVID-19 Antigen Home Test (Model: 2T/Kit)
0
-
Boson - Rapid SARS-CoV-2 Antigen Test Card - 2 Tests/Kit
Xiamen Boson Biotech Co., Ltd.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
0
-
Boson - Rapid SARS-CoV-2 Antigen Test Card - 4 Tests/Kit
Xiamen Boson Biotech Co., Ltd.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
0
-
Boson - Rapid SARS-CoV-2 Antigen Test Card - 10 Tests/Kit
Xiamen Boson Biotech Co., Ltd.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
0
-
Boson - Rapid SARS-CoV-2 Antigen Test Card - 40 Tests/Kit
Xiamen Boson Biotech Co., Ltd.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
0
-
Boson - Rapid SARS-CoV-2 Antigen Test Card - 8 Tests/Kit
Xiamen Boson Biotech Co., Ltd.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
0
-
Boson - Rapid SARS-CoV-2 Antigen Test Card - 20 Tests/Kit
Xiamen Boson Biotech Co., Ltd.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
0
-
Boson - Rapid SARS-CoV-2 Antigen Test Card - 5 Tests/Kit
Xiamen Boson Biotech Co., Ltd.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
0
-
Boson - Rapid SARS-CoV-2 Antigen Test Card - 2 Tests/Kit
Xiamen Boson Biotech Co., Ltd.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
0
-
Boson - Rapid SARS-CoV-2 Antigen Test Card - 1 Tests/Kit
Xiamen Boson Biotech Co., Ltd.
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
0
-
Rapid SARS-CoV-2 Antigen Test Card
LUMIQUICK DIAGNOSTICS, INC.
The Rapid SARS-CoV-2 Antigen Test Card is a single use rapid lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 and older, when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.This test is also authorized for non-prescription home use with adult-collected anterior nasal (nares) swab samples from individuals aged 2 years and older when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals aged 2 years and older with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.